Since patients with AR/ER ratio ≥2 show worse disease-free survival in the presence of anti-estrogen therapies or chemotherapy treatment compared to patients with lower ratio [26, 27], we wondered if Cd could alter the AR/ER ratio in our BC cellular in vitro models. The gene discussed is ESR1; the disease is breast cancer.